That's about right. Shorts covering and people selling the news are probably close to equal. IMO we get a bump up but doubt it would be over 10 percent. If biotech is down Monday it will try to go down with it. If an ETF holds shares and they get hammered, they have to sell acad shares too. But it should run into and during commercialization